Cefoxitin: Difference between revisions

Revision as of 14:56, 27 March 2024 view source Alexander Berchansky (talk \| contribs) 29,726 edits No edit summary ← Older edit		Revision as of 14:59, 27 March 2024 view source Alexander Berchansky (talk \| contribs) 29,726 edits No edit summary Newer edit →
Line 1:		Line 1:
	<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''>		<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1040131/Cv/1'>
	Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. See also [https://en.wikipedia.org/wiki/Cefoxitin Cefoxitin].		Cefoxitin is a second-generation cephamycin antibiotic developed by Merck & Co., Inc. from Cephamycin C in the year following its discovery, 1972. See also [https://en.wikipedia.org/wiki/Cefoxitin Cefoxitin].

Navigation menu